UT Southwestern has received more than $34 million for cancer research. The grant was given by the Cancer Prevention and Research Institute of Texas.
UT Southwestern’s total CPRIT award of $34,265,689 includes the following for research and facilities: core facility support awards, individual investigator awards, high-impact, and high-risk awards. The grant also supports research and faculty recruitment at UT Southwestern.
According to UT Southwestern, funding will go toward further developing programs in pancreatic cancer, lung cancer, breast cancer, and melanoma.
Dr. Carlos Arteaga, director of UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center, told D CEO Healthcare he plans to use the grant funds to make UT Southwestern “one of the top institutions in the nation for conducting laboratory-based translational cancer medicine. At a time in which there is so much momentum in cancer discovery and cancer care but also serious clouds in the research funding horizon, the support from CPRIT is an inspirational example of the commitment of the state of Texas to maintaining and enhancing the pace of progress in cancer research.”
Dr. Daniel Podolsky, president of UT Southwestern, added in a statement: “These CPRIT awards will support translational and clinical research initiatives at UT Southwestern that hold great potential to improve cancer treatments.”
